L Mondragón Lab_IJC

T cell lymphomas group at @CarrerasIJC

[Bial Foundation @bialfoundation]

🏆 On behalf ofthe entire research team, Laurence Zitvogel, @GustaveRoussy, @UnivParisSaclay, took to the stageto express gratitude for being awarded the #BialAwardinBiomedicine 2025, highlighting that in 2018, herteam discovered “that gutmicrobiota had a fundamental impact on immune response, facilitating new therapies for cancer treatment”.

📽️ This was followed by a video presentation ofthe research behind the winning study, which showed how the use of antibiotics can negatively impact the effectiveness of immunotherapy by reducing gutmicrobiota diversity. Analysis of cancer patients revealed that greater bacterial diversity is associated with better clinical outcomes.

#BialFoundation #Biomedicine #Cancer #Immunology

[Bial Foundation @bialfoundation]

🎙️Next, in his introductoryspeech to the awardwinners, Ralph Adolphs, President ofthe Jury, highlighted that the selected study represents “a remarkable scientific breakthrough that opens new therapeutic avenues and exemplifies the transformative power of excellence in biomedical research”.

🔜 Stay tuned for the long-awaitedmoment ofthe #BialAwardinBiomedicine Ceremonynext! Watch it live on @Publico 's YouTube channel👉 https://t.co/gcPKv9s1Yk

#BialFoundation #Biomedicine #Cancer #Immunology

[Bial Foundation @bialfoundation]

🏆 The winning study ofthe #BialAwardinBiomedicine 2025, publishedin @ScienceMagazine in 2018, “Gut microbiome influences efficacy ofPD-1–based immunotherapy against epithelial tumors,” documents one ofthe mostsignificant recent advances in the treatment of several types of cancer, as it establishesthat the gut microbiome- the collection of bacteria residingin the human intestine - plays a decisiverole in the effectiveness of immunotherapy.

🙌 Congratulations to all 48 international researchers involvedin this award‑winning study. Takingthe stageare the lead authors, Laurence Zitvogel and Guido Kromer , internationally renowned French academics, accompanied by the first authorsBertrand Routy, Emmanuelle Le Chatelier and @derosa_lisa.

🎓@GustaveRoussy, @UnivParisSaclay, Université Paris Cité, Assistance Publique - Hôpitaux de Paris, Aix-Marseille University, @Inserm, @laliguecancer, @MgpsLab, EverImmune, @HParisStJoseph, Rennes Private Hospitals – Saint-Grégoire (Vivalto Santé), @CGFL_Dijon, Artimmune/INEM, @hopitalbichat (FR); Hospital Clinic of Barcelona, University of Barcelona, @CarrerasIJC (ES); University Hospital Heidelberg, @DKFZ, @TU_Muenchen, Ludwig Maximilians University (GE), @AstraZeneca (UK), @LeicaBio (US); University of Montreal Hospital Research Centre (CRCHUM), @UCalgary (CA), @CSL (AU), e Changchun GeneScience Pharmaceutical Co (CN).
#BialFoundation #Biomedicine #Cancer #Immunology

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

Fem equip amb #LaMarató3Cat 2025, dedicada al càncer! 💪

Per conèixer el present i futur dels càncers de la sang, @BadalonaTres60 va entrevistar el Dr. Ribera i la Dra. Mondragón, investigadors de l'IJC.

⏰ 6:56 👉 https://t.co/c5NOOJ3X2h

🙌 Pots fer el teu donatiu a https://t.co/xIjjGKlsFD

@la_marato @MondragonLab

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

🩸 Did you know #lymphoma affects over 600,000 people worldwide each year?

🔬 On #WorldLymphomaAwarenessDay, we spotlight the vital role of research and introduce our two labs dedicated to fighting this disease.

👉https://t.co/xakGuRKv71

👉https://t.co/Y6qxDJIUSn

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

Tornem a la #NitRecerCat! 🔬🌙

🗨️ El futur de la leucèmia a debat: recerca computacional 💻, bàsica 🧬 i clínica 💊

🗓️ 23/09 · 18 h
📍 Biblioteca G. García Márquez, Barcelona

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

We are pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Leukaemia Research Institute.

Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases.

Read the full release here: https://t.co/1FNJ87VRZN

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

Feliç Diada de Sant Jordi des de l’IJC! 🌹📚

We marked the day with a book & rose exchange organized by the IJC–@GTRecerca Reading Club, promoting culture within our research community.

Thanks to everyone who joined 🩵

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

📣 On today's Young Researchers Seminars, Barbara Chalhoub 👩‍🔬 (@MondragonLab) discussed APAF-1 deficiency in tumor progression, while Víctor Sánchez 👨‍🔬 (@ManelEsteller lab) shared insights on novel treatments to enhance cancer immunotherapy 🧪🧫

Well done, young researchers!✨🔬

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

💜 This #InternationalWomensDay, we reaffirm our commitment to gender equality. At @carrerasijc, we actively work to close the gap, improve opportunities, and make our institute a true benchmark for inclusion.

Together, we create change!✨🚀

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

Different languages, one mission: curing leukemia 💪

🔬🌍 At the IJC, researchers from all over the world come together through science. On #InternationalMotherTongueDay, we are committed to collaborative, inclusive and multicultural research 🫂

💙 Together we are unstoppable!

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

👩‍🔬👏 Laura Mondragón (@MondragonLab), una de las 100 científicas de la 3a edición de 'Nanocientíficas en 60 segundos' de @icmm_csic

📝 Este concurso, dirigido al alumnado de Secundaria 🎒, divulga el trabajo de investigadoras españolas vinculadas a la nanociencia y la tecnología 🚀

Sientes curiosidad? 👀 https://t.co/qeXtgVeIHi

[Instituto de Ciencia de Materiales Madrid - CSIC @icmm_csic]

🥳¡¡¡VUELVE!!!
💪Llega la III edición de nuestro concurso de #Nanocientíficas en 60 segundos, ¡este año con doble premio! Uno general y otro de sostenibilidad (@SNSSNano)
👉DEADLINE. 11 de abril
🤝Toda la info:
https://t.co/5uA3v0kW73

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

👩‍🔬 On the #InternationalDayOfWomenAndGirlsInScience, we’re glad to announce that ✅ #Hipàtia has created a simple tool to help researchers assess gender integration in science,🚀 promoting more inclusive and high-quality research 🧑‍🤝‍🧑

Downloadit here🔗 👇https://t.co/2NfL9TmlUT

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

🎄 Des de l’Institut Josep Carreras, us desitgem a tots i totes un bon Nadal! ✨

🎅 The Josep Carreras Institute wishes you a Merry Christmas! ✨

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

KICK OFF!!
The 2024 #IJCSymposium has just started and the first speakers are sharing their research to a woderfully crowded auditorium.

Connecting minds is the best way to move forward.
Today, as always, together we are unstoppable!

Keep tuned for updates!

[Josep Carreras Leukaemia Research Institute (IJC) @CarrerasIJC]

💪Orgullosos de nuestra representación en el 19 congreso @ASEICAnews:

✅Gregoire Stick (@G_Stik) - Ganador VI Ayuda +queuntrail - ASEICA
✅Laura Mondragón (@MondragonLab) - II Ayda Fundación Domingo Martínez - ASEICA Accesit

✅Y las charlas de @eli_mereu y @LucPontel

[L Mondragón Lab_IJC @MondragonLab]

Extremadamente agradecida por el accésit recibido a través de la II AYUDA FUNDACIÓN DOMINGO MARTINEZ - ASEICA por nuestro proyecto centrado en estudiar defectos metabólicos durante la timopoiesis y su conexión con los linfomas T
@ASEICAnews
@CarrerasIJC
🔬

[ASEICA @ASEICAnews]

@DraAnaCasas @actitud_cancer @CNB_CSIC @fundacionsi @marta_puyol @ContraCancerEs @FundacionMQI @msmelanoma @FundacionFero @IIBmCSICUAM @CuendaAna @ArkaitzLab @imos_indo @psancholab @AJSchuhmy 📍II AYUDA FUNDACIÓN DOMINGO MARTINEZ - ASEICA

➡️ Otorga 25.000€ euros a Ana V.Lechuga-Vieco (@avlecvie)

✏️ Understanding mitochondrial genetic signatures: from cancer cellbehaviour to tumour microenvironment dynamics

ACCÉSITS: Marta Montes y @MondragonLab

#ASEICACongress

[XV ApoRed meeting @ApoReunion]

Let’s get started with Session II. Our first speaker is Gaël Roué @gaelroueBCN from @CarrerasIJC who will discuss his results on the design and characterisation of an inhibitor against B-cell non-Hodgkin lymphoma

@HaploXGlobal @ebioNova @MedChemExpress @Co_Biologists #Condalab